ConductScience.org, home

Trial · NCT01149486

Results by group18

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Cmax of Losartan(Maximum Observed Concentration of Drug Substance in Plasma)Losartan/HCTZ (Test)509.63Standard Deviation 314.75ng/mL
Cmax of Losartan(Maximum Observed Concentration of Drug Substance in Plasma)Hyzaar® (Reference)538.11Standard Deviation 298.89ng/mL
AUC0-t of Losartan(Area Under the Concentration-time Curve From Time Zero to Time of Last Measurable Concentration)Losartan/HCTZ (Test)866.88Standard Deviation 366.15ng*h/mL
AUC0-t of Losartan(Area Under the Concentration-time Curve From Time Zero to Time of Last Measurable Concentration)Hyzaar® (Reference)865.00Standard Deviation 362.86ng*h/mL
AUC0-inf of Losartan(Area Under the Concentration-time Curve From Time Zero to Infinity)Losartan/HCTZ (Test)880.15Standard Deviation 368.58ng*h/mL
AUC0-inf of Losartan(Area Under the Concentration-time Curve From Time Zero to Infinity)Hyzaar® (Reference)877.99Standard Deviation 362.75ng*h/mL
Cmax of Hydroclorothiazide(Maximum Observed Concentration of Drug Substance in Plasma)Losartan/HCTZ (Test)177.63Standard Deviation 48.09ng/mL
Cmax of Hydroclorothiazide(Maximum Observed Concentration of Drug Substance in Plasma)Hyzaar® (Reference)161.56Standard Deviation 53.75ng/mL
AUC0-t of Hydrochlorothiazide(Area Under the Concentration-time Curve From Time Zero to Time of Last Measurable Concentration)Losartan/HCTZ (Test)1057.58Standard Deviation 231.26ng*h/mL
AUC0-t of Hydrochlorothiazide(Area Under the Concentration-time Curve From Time Zero to Time of Last Measurable Concentration)Hyzaar® (Reference)1001.54Standard Deviation 236.00ng*h/mL
AUC0-inf of Hydrochlorothiazide(Area Under the Concentration-time Curve From Time Zero to Infinity)Losartan/HCTZ (Test)1087.64Standard Deviation 240.82ng*h/mL
AUC0-inf of Hydrochlorothiazide(Area Under the Concentration-time Curve From Time Zero to Infinity)Hyzaar® (Reference)1030.73Standard Deviation 238.96ng*h/mL
Cmax of Losartan Carboxy Acid(Maximum Observed Concentration of Drug Substance in Plasma)Losartan/HCTZ (Test)726.85Standard Deviation 210.78ng/mL
Cmax of Losartan Carboxy Acid(Maximum Observed Concentration of Drug Substance in Plasma)Hyzaar® (Reference)675.54Standard Deviation 197.25ng/mL
AUC0-t of Losartan Carboxy Acid(Area Under the Concentration-time Curve From Time Zero to Time of Last Measurable Concentration)Losartan/HCTZ (Test)4236.78Standard Deviation 1176.34ng*h/mL
AUC0-t of Losartan Carboxy Acid(Area Under the Concentration-time Curve From Time Zero to Time of Last Measurable Concentration)Hyzaar® (Reference)4117.07Standard Deviation 1087.67ng*h/mL
AUC0-inf of Losartan Carboxy Acid(Area Under the Concentration-time Curve From Time Zero to Infinity)Losartan/HCTZ (Test)4281.32Standard Deviation 1182.77ng*h/mL
AUC0-inf of Losartan Carboxy Acid(Area Under the Concentration-time Curve From Time Zero to Infinity)Hyzaar® (Reference)4164.62Standard Deviation 1096.64ng*h/mL

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01149486/results